Optiscan Imaging Limited (ASX:OIL) has completed the first prototype to collect images from the gastrointestinal (GI) tract ...

Medtech company Optiscan Imaging has rolled out a flexible endomicroscope prototype capable of capturing real-time images ...

The study will assess Optiscan’s Gen2 real-time imaging capability to diagnose and treat GI diseases, including cancer Optiscan Imaging Limited (ASX:OIL) has completed the first prototype to ...

Fujifilm identified a training gap in the U.S. market for ESD and POEM procedures, which are cutting-edge and lifesaving minimally invasive endoscopic surgical procedure more widely in Asian ...

Optiscan said the collected images would be used to assess real-time imaging capability of its Gen2 technology in diagnosing and treating GI diseases, including cancer, and progress planning for ...

Gastrointestinal involvement is common among patients with EGPA, with eosinophilic tissue infiltration, weight loss, and myalgia identified as significant predictors.

The chronic diseases such as cancer, cardiovascular diseases is a factor driving the growth of the Global Diagnostic Imaging Agent Market. US, NY, UNITED STATES, January 31, 2025 /EINPresswire / -- ...